InsiderClue
Stocks · Health care · Services-Commercial Physical & Biological Research

OmniAb, Inc.

OABI Clue Score25
United States Fiscal year ends December CIK 0001846253 Results filed 30 Oct 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

14
Insider
Date
Role
Action
Shares
Price
Amount
Charles S Berkman
7 Apr 2026
Chief Legal Officer
Sold after exercise
7,157
$1.49
$10.66K
Kurt A Gustafson
7 Apr 2026
Executive VP, Finance and CFO
Sold after exercise
6,913
$1.49
$10.30K
Matthew W Foehr
7 Apr 2026
President and CEO
Sold after exercise
19,244
$1.49
$28.67K
Matthew W Foehr
18 Feb 2026
President and CEO
Sold after exercise
30,843
$1.71
$52.74K
Kurt A Gustafson
18 Feb 2026
Executive VP, Finance and CFO
Sold after exercise
9,301
$1.71
$15.90K
Charles S Berkman
18 Feb 2026
Chief Legal Officer
Sold after exercise
9,673
$1.71
$16.54K
Kurt A Gustafson
7 Apr 2025
Executive VP, Finance and CFO
Sold after exercise
7,206
$2.00
$14.41K
Charles S Berkman
7 Apr 2025
Chief Legal Officer
Sold after exercise
7,206
$2.00
$14.41K
Matthew W Foehr
7 Apr 2025
President and CEO
Sold after exercise
19,382
$2.00
$38.76K
Kurt A Gustafson
1 Apr 2025
Executive VP, Finance and CFO
Sold after exercise
11,963
$2.37
$28.35K
Kurt A Gustafson
1 Apr 2024
Executive VP, Finance & CFO
Sold after exercise
11,849
$5.46
$64.70K
John L Higgins
23 May 2023
Director
Sold after exercise
9,000
$4.05
$36.45K
John L Higgins
19 May 2023
Director
Sold after exercise
1,000
$4.05
$4.05K
John L Higgins
18 May 2023
Director
Sold after exercise
50,000
$3.89
$194.50K
Show all 64 transactions →

What was left out

Form 4 filings counted 142
Amendments (4/A) skipped 7
Filings about a different issuer 0
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 14
Sales at will 19
Transactions with no price 0
Shares from compensation/vesting 49,829,295
History held since 3 Nov 2022